WASHINGTON—The average annual cost of therapy for one widely used brand-name prescription drug in 2017 was over 18 times higher than the cost of therapy for one generic drug, according to a new...

WASHINGTON—The following is a statement from AARP Executive Vice President and Chief Advocacy & Engagement Officer Nancy LeaMond on the approval of two bills endorsed by AARP: Creating and...

WASHINGTON—AARP and AARP Foundation filed an amicus brief today with the United States Court of Appeals for the Fifth Circuit supporting the constitutionality of the Patient Protection and...

WASHINGTON—The following is a statement from AARP Executive Vice President and Chief Advocacy & Engagement Officer Nancy LeaMond on Stewart v. Azar and Gresham v. Azar: “AARP is heartened by...

WASHINGTON—The following is a statement from AARP Executive Vice President and Chief Advocacy & Engagement Officer Nancy LeaMond on the approval of two bills endorsed by AARP: Creating and...

WASHINGTON—Today, AARP announced the launch of ‘Stop Rx Greed,’ a nationwide campaign aimed at lowering prescription drug prices. The goal of AARP’s sustained campaign is to help drive...

WASHINGTON—Today, AARP released the following statement from Executive Vice President and Chief Advocacy & Engagement Officer Nancy LeaMond. The statement is in response to seven drug company...

WASHINGTON—AARP has opened applications for the 2019 AARP Community Challenge grant program to fund “quick-action” projects that spark change across the country. Now in its third year, the...

WASHINGTON—Primary care providers agree, almost unanimously, that family caregivers play a vital role in patient care and in better patient outcomes, according to a new survey by AARP Research.

WASHINGTON, DC—AARP CEO Jo Ann Jenkins released the following statement in response to the State of the Union address this evening: “In tonight’s State of the Union address, AARP was...